These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20656632)

  • 1. High-resolution coronary imaging by optical coherence tomography: Feasibility, pitfalls and artefact analysis.
    Motreff P; Levesque S; Souteyrand G; Sarry L; Ouchchane L; Citron B; Cassagnes J; Lusson JR
    Arch Cardiovasc Dis; 2010 Apr; 103(4):215-26. PubMed ID: 20656632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography.
    Okamura T; Onuma Y; Garcia-Garcia HM; van Geuns RJ; Wykrzykowska JJ; Schultz C; van der Giessen WJ; Ligthart J; Regar E; Serruys PW
    EuroIntervention; 2011 Apr; 6(9):1037-45. PubMed ID: 21518674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
    Brown AJ; McCormick LM; Hoole SP; West NE
    JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention.
    Imola F; Mallus MT; Ramazzotti V; Manzoli A; Pappalardo A; Di Giorgio A; Albertucci M; Prati F
    EuroIntervention; 2010 Nov; 6(5):575-81. PubMed ID: 21044910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-domain optical coherence tomography assessment of unfavorable kissing-balloon result in unprotected left main intervention.
    Fujino Y; Attizzani GF; Tahara S; Takagi K; Bezerra HG; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1324-5. PubMed ID: 24355122
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications.
    Bezerra HG; Costa MA; Guagliumi G; Rollins AM; Simon DI
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1035-46. PubMed ID: 19926041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre evaluation of the safety of intracoronary optical coherence tomography.
    Barlis P; Gonzalo N; Di Mario C; Prati F; Buellesfeld L; Rieber J; Dalby MC; Ferrante G; Cera M; Grube E; Serruys PW; Regar E
    EuroIntervention; 2009 May; 5(1):90-5. PubMed ID: 19577988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
    Tamburino C; La Manna A; Di Salvo ME; Sacchetta G; Capodanno D; Mehran R; Dangas G; Corcos T; Prati F
    JACC Cardiovasc Interv; 2009 Mar; 2(3):197-204. PubMed ID: 19463426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography.
    Chamié D; Bezerra HG; Attizzani GF; Yamamoto H; Kanaya T; Stefano GT; Fujino Y; Mehanna E; Wang W; Abdul-Aziz A; Dias M; Simon DI; Costa MA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):800-13. PubMed ID: 23871510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year follow-up of the first Cypher stent implanted in human: an invasive evaluation with angiography, intravascular ultrasound, and optical coherence tomography.
    Sousa JE; Costa JR; Abizaid A
    JACC Cardiovasc Interv; 2010 May; 3(5):556-8. PubMed ID: 20488413
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of an eccentric intravascular ImageWire during coronary optical coherence tomography imaging.
    Suzuki N; Guagliumi G; Bezerra HG; Sirbu V; Rosenthal N; Musumeci G; Aprile A; Wang H; Kyono H; Tahara S; Simon DI; Rollins A; Costa MA
    EuroIntervention; 2011 Mar; 6(8):963-9. PubMed ID: 21330244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography: from physical principles to clinical applications.
    Hamdan R; Gonzalez RG; Ghostine S; Caussin C
    Arch Cardiovasc Dis; 2012 Oct; 105(10):529-34. PubMed ID: 23062484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary optical diagnostics current status, limitations, and potential.
    Lowe HC; Narula J; Fujimoto JG; Jang IK
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1257-70. PubMed ID: 22192367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion.
    Takarada S; Imanishi T; Liu Y; Ikejima H; Tsujioka H; Kuroi A; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Kubo T; Nakamura N; Hirata K; Tanaka A; Mizukoshi M; Akasaka T
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):202-6. PubMed ID: 19937788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of STEMI arising from plaque erosion.
    Holmes DR; Lerman A; Moreno PR; King SB; Sharma SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):290-6. PubMed ID: 23473111
    [No Abstract]   [Full Text] [Related]  

  • 19. Optical coherence tomography: a new tool to detect tissue coverage in drug-eluting stents.
    Di Mario C; Barlis P
    JACC Cardiovasc Interv; 2008 Apr; 1(2):174-5. PubMed ID: 19463296
    [No Abstract]   [Full Text] [Related]  

  • 20. Method analysis for optimal continuous imaging using intravascular optical coherence tomography.
    Asawa K; Kataoka T; Kobayashi Y; Hasegawa T; Nishioka H; Yamashita H; Qiu Z; Ehara S; Hirose M; Kamimori K; Shimada K; Yoshiyama M; Yoshikawa J
    J Cardiol; 2006 Mar; 47(3):133-41. PubMed ID: 16570535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.